Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Catalyst Pharmaceuticals (CPRX) Gross Profit (2019 - 2026)

Catalyst Pharmaceuticals filings provide 8 years of Gross Profit readings, the most recent being $134.9 million for Q1 2026.

  • On a quarterly basis, Gross Profit rose 9.23% to $134.9 million in Q1 2026 year-over-year; TTM through Mar 2026 was $513.1 million, a 11.45% increase, with the full-year FY2025 number at $501.7 million, up 18.64% from a year prior.
  • Gross Profit hit $134.9 million in Q1 2026 for Catalyst Pharmaceuticals, up from $126.5 million in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $134.9 million in Q1 2026 to a low of $37.2 million in Q1 2022.
  • Median Gross Profit over the past 5 years was $94.8 million (2023), compared with a mean of $93.3 million.
  • Biggest five-year swings in Gross Profit: skyrocketed 102.75% in 2023 and later rose 5.29% in 2025.
  • Catalyst Pharmaceuticals' Gross Profit stood at $49.6 million in 2022, then soared by 91.19% to $94.8 million in 2023, then rose by 26.82% to $120.2 million in 2024, then rose by 5.29% to $126.5 million in 2025, then grew by 6.62% to $134.9 million in 2026.
  • The last three reported values for Gross Profit were $134.9 million (Q1 2026), $126.5 million (Q4 2025), and $125.7 million (Q3 2025) per Business Quant data.